Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0568B | Benzodiazepines Screen, Blood |
0568FL | Benzodiazepines Screen, Fluid |
0568SP | Benzodiazepines Screen, Serum/Plasma |
0568U | Benzodiazepines Screen, Urine |
0770B | Brompheniramine, Blood |
0770SP | Brompheniramine, Serum/Plasma |
0770U | Brompheniramine, Urine |
2111B | Baclofen, Blood |
2111FL | Baclofen, Fluid |
2111SP | Baclofen, Serum/Plasma |
2111U | Baclofen, Urine |
6922H | Benzodiazepines Screen, Hair |
8891OF | Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
9118B | Brompheniramine Screen, Blood |
9329B | Benzodiazepines Panel, Blood |
9329FL | Benzodiazepines Panel, Fluid |
9329ME | Benzodiazepines Panel (Qualitative), Meconium |
9329SP | Benzodiazepines Panel, Serum/Plasma |
9329TI | Benzodiazepines Panel, Tissue |
9329U | Benzodiazepines Panel, Urine |
9351UC | Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |